News

Schroth is expected to oversee the company’s biology and chemistry research, the development of new genomic applications, and the SmartChip Gene-Expression Profiling Services offered by WaferGen scientists at

The partnership is expected to strengthen StayinFront’s position in Eastern Europe, Russia and CIS and consolidates the physician database and CRM software provision for the region. Morion’s sales

The seven Europeon countries in the agreement include Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia and Slovenia. Health Robotics said that its software and related technologies will finally enable

Cellectis bioresearch Inc, which is located at the Cambridge Innovation Center in Cambridge, Massachusetts, is expected to be responsible for the US-wide promotion of Cellectis bioresearch products and

Systane Balance is indicated for patients with Meibomian Gland Dysfunction (MGD) who are unable to adequately prevent the evaporation of tears, resulting in dry eye symptoms. Alcon claimed

In addition, a working group, set up recently, will formulate an agenda for action to pave the way for putting in place a permanent infrastructure securing vaccine R&D

ImaginAb claimed that its recombinant antibody fragments enable development of tailored, specific imaging agents for drug research. Imanet claimed that its network of Positron Emission Tomography (PET) imaging

NuPathe said that the first trial compared the pharmacokinetics of Zelrix in healthy elderly volunteers to healthy young adult volunteers and the pharmacokinetics of Zelrix applied to the

As per the terms of the agreement, Novartis is expected to pay a $45m upfront fee to ImmunoGen for exclusive rights to use ImmunoGen’s Targeted Antibody Payload (TAP)